Objective Both belimumab and telitacicept are recognised blockers for B lymphocyte activation, both of which have been ...

Among those treated for sarcoidosis in the year following diagnosis, 60% used steroids alone, 13% nonsteroidal immunosuppressives alone, and 27% received both. About 43% of patients with sarcoidosis ...

High serum CXCL13 levels are predictive of treatment failure with first-line MTX among patients with early RA.

A POPULAR nasal spray used to tackle a blocked nose may trigger Parkinson’s disease-like symptoms, a doctor has warned. Pseudoephedrine, a medicine found in many cold and flu medicines like ...

Funky Time Tracker Zhejiang Pharmaceutical Norfloxacin Tablets is the first to pass the consistency evaluation Sanofi's new CEO announces his plan to ...

A previously unknown disease making the rounds in the Democratic Republic of Congo (DRC) is a severe form of malaria, the country’s health ministry has announced. Health authorities on Tuesday ...

This unsettling event has reignited discussions about “Disease X.” Disease X is not an actual but a hypothetical disease. The World Health Organization (WHO) coined the term in 2018 to ...

A view of the Panzi General Referral Hospital in southwestern Democratic Republic of the Congo, which has seen an outbreak of a mystery disease [Lucien Lufutu/AP] Goma, Democratic Republic of the ...

Congo, which is as big as the US states of Alaska and Texas combined, reported another 147 cases of the flu-like illness dubbed “Disease X” in the past week, Africa Centres for Disease Control ...

Study: Estimated global and regional incidence and prevalence of herpes simplex virus infections and genital ulcer disease in 2020: mathematical modelling analyses. Image Credit: sokolova_sv ...

JOHANNESBURG – Dozens of people have died and hundreds have been struck by a flu-like illness dubbed Disease X that was first detected in a remote region of the Democratic Republic of Congo in ...

Andrea Kaston Tange does not work for, consult, own shares in or receive funding from any company or organization that would benefit from this article, and has disclosed no relevant affiliations ...